drugset / Trial / NCT00091039
Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery
Completed
National Cancer Institute (NCI)
Treatment
Summary
RATIONALE: Vaccines made from a gene-modified virus may make the body build an immune response to kill tumor cells. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high energy x-rays to damage tumor cells. Combining vaccine therapy with chemotherapy and radiation therapy may kill more tumor cells. PURPOSE: This clinical trial is studying how well giving vaccine therapy together with paclitaxel, carboplatin, and radiation therapy works in treating patients with stage III non-small cell lung cancer that cannot be removed with surgery.
Timeline
- Start
- 2004-08
- Primary completion
- —
- Completion
- 2006-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | Intravenous |
| Subject | Paclitaxel | Small molecule | — | Intravenous |
| Subject | recombinant fowlpox GM-CSF vaccine | Vaccine | — | Subcutaneous |
| Subject | recombinant fowlpox-CEA(6D)/TRICOM vaccine | Vaccine | — | Subcutaneous |
| Subject | recombinant vaccinia-CEA(6D)-TRICOM vaccine | Vaccine | — | Subcutaneous |